{"id":7163,"date":"2012-04-22T14:28:31","date_gmt":"2012-04-22T14:28:31","guid":{"rendered":"http:\/\/cardiophile.org\/?p=7163"},"modified":"2023-07-22T21:50:38","modified_gmt":"2023-07-22T16:20:38","slug":"nephrogenic-systemic-fibrosis","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/","title":{"rendered":"Nephrogenic systemic fibrosis"},"content":{"rendered":"<p><iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/hC2ycBbKMRU\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" allowfullscreen=\"\"><\/iframe><\/p>\n<h2><span style=\"color: #008000;\">Nephrogenic systemic fibrosis<\/span><\/h2>\n<p>In earlier era, magnetic resonance imaging was considered as a safe modality of imaging in those with renal failure because it did not have the potential for contrast induced nephropathy which could occur with radiocontrast imaging. But when nephrogenic systemic fibrosis was described as an association with gadolinium based contrast agents, more caution was called for in magnetic resonance imaging in severe renal dysfunction. This led to less use of gadolinium enhanced magnetic resonance imaging in patients with severe renal failure who are at risk of nephrogenic systemic fibrosis. This has led to virtual elimination of new cases of nephrogenic systemic fibrosis according to Zou et al [1] who reviewed three hundred and seventy cases from ninety eight published articles.<\/p>\n<p><span style=\"color: #0000ff;\"><strong>Reference<\/strong><\/span><\/p>\n<ol>\n<li>Zhitong Zou, Hong Lei Zhang, Giles H Roditi, Tim Leiner, Walter Kucharczyk, Martin R Prince. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22093272\/\">Nephrogenic Systemic Fibrosis. Review of 370 Biopsy-Confirmed Cases<\/a>. JACC Cardiovasc Imaging. 2011; 4:1206-1216.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Nephrogenic systemic fibrosis is described as an association with gadolinium based contrast agents in those with renal failure.<\/p>\n","protected":false},"author":1,"featured_media":60336,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[20],"tags":[],"class_list":["post-7163","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cardiac-magnetic-resonance-imaging"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nephrogenic systemic fibrosis - gadolinium based contrast associated<\/title>\n<meta name=\"description\" content=\"Nephrogenic systemic fibrosis is described as an association with gadolinium based contrast agents in those with renal failure.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nephrogenic systemic fibrosis - gadolinium based contrast associated\" \/>\n<meta property=\"og:description\" content=\"Nephrogenic systemic fibrosis is described as an association with gadolinium based contrast agents in those with renal failure.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2012-04-22T14:28:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-22T16:20:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2012\/04\/Nephrogenic-Systemic-Fibrosis.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"893\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/nephrogenic-systemic-fibrosis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/nephrogenic-systemic-fibrosis\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Nephrogenic systemic fibrosis\",\"datePublished\":\"2012-04-22T14:28:31+00:00\",\"dateModified\":\"2023-07-22T16:20:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/nephrogenic-systemic-fibrosis\\\/\"},\"wordCount\":152,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/nephrogenic-systemic-fibrosis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2012\\\/04\\\/Nephrogenic-Systemic-Fibrosis.jpg\",\"articleSection\":[\"Cardiac Magnetic Resonance imaging\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/nephrogenic-systemic-fibrosis\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/nephrogenic-systemic-fibrosis\\\/\",\"name\":\"Nephrogenic systemic fibrosis - gadolinium based contrast associated\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/nephrogenic-systemic-fibrosis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/nephrogenic-systemic-fibrosis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2012\\\/04\\\/Nephrogenic-Systemic-Fibrosis.jpg\",\"datePublished\":\"2012-04-22T14:28:31+00:00\",\"dateModified\":\"2023-07-22T16:20:38+00:00\",\"description\":\"Nephrogenic systemic fibrosis is described as an association with gadolinium based contrast agents in those with renal failure.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/nephrogenic-systemic-fibrosis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/nephrogenic-systemic-fibrosis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/nephrogenic-systemic-fibrosis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2012\\\/04\\\/Nephrogenic-Systemic-Fibrosis.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2012\\\/04\\\/Nephrogenic-Systemic-Fibrosis.jpg\",\"width\":1200,\"height\":893},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/nephrogenic-systemic-fibrosis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nephrogenic systemic fibrosis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nephrogenic systemic fibrosis - gadolinium based contrast associated","description":"Nephrogenic systemic fibrosis is described as an association with gadolinium based contrast agents in those with renal failure.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/","og_locale":"en_US","og_type":"article","og_title":"Nephrogenic systemic fibrosis - gadolinium based contrast associated","og_description":"Nephrogenic systemic fibrosis is described as an association with gadolinium based contrast agents in those with renal failure.","og_url":"https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2012-04-22T14:28:31+00:00","article_modified_time":"2023-07-22T16:20:38+00:00","og_image":[{"width":1200,"height":893,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2012\/04\/Nephrogenic-Systemic-Fibrosis.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Nephrogenic systemic fibrosis","datePublished":"2012-04-22T14:28:31+00:00","dateModified":"2023-07-22T16:20:38+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/"},"wordCount":152,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2012\/04\/Nephrogenic-Systemic-Fibrosis.jpg","articleSection":["Cardiac Magnetic Resonance imaging"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/","url":"https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/","name":"Nephrogenic systemic fibrosis - gadolinium based contrast associated","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2012\/04\/Nephrogenic-Systemic-Fibrosis.jpg","datePublished":"2012-04-22T14:28:31+00:00","dateModified":"2023-07-22T16:20:38+00:00","description":"Nephrogenic systemic fibrosis is described as an association with gadolinium based contrast agents in those with renal failure.","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2012\/04\/Nephrogenic-Systemic-Fibrosis.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2012\/04\/Nephrogenic-Systemic-Fibrosis.jpg","width":1200,"height":893},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/nephrogenic-systemic-fibrosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Nephrogenic systemic fibrosis"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/7163","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=7163"}],"version-history":[{"count":4,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/7163\/revisions"}],"predecessor-version":[{"id":60338,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/7163\/revisions\/60338"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/60336"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=7163"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=7163"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=7163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}